Gagnon Neil 13D and 13G filings for Apollo Endosurgery, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 4:10 pm Sale | 2023-02-02 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Neil | 717,490 1.700% | -3,013,401 (-80.77%) | Filing |
| 2023-02-06 4:05 pm Purchase | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Neil | 3,730,891 9.000% | 342,812 (+10.12%) | Filing |
| 2022-02-03 4:21 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Neil | 3,388,079 8.600% | 389,601 (+12.99%) | Filing |
| 2021-02-05 4:27 pm Purchase | 2020-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Neil | 2,998,478 11.600% | 362,706 (+13.76%) | Filing |
| 2020-10-13 4:10 pm Purchase | 2020-10-08 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Neil | 2,635,772 10.720% | 533,720 (+25.39%) | Filing |